Zhang SP, Huang TT, Zeng QL, Luo WJ, Xiong YJ, Peng C, Lian F, Cheng QF, Wang ZH, Huang W, Xu Y, Li QF, Yang SM, Chen XJ, Hu JB, Li XY. Higher diversity of anti-diabetic therapy is associated with lower risk of major adverse kidney events in diabetes. World J Diabetes 2026; 17(11): 123922 [DOI: 10.4239/wjd.123922]